标题
Modes of action of TLR7 agonists in cancer therapy
作者
关键词
-
出版物
Immunotherapy
Volume 6, Issue 10, Pages 1085-1095
出版商
Future Medicine Ltd
发表日期
2014-11-27
DOI
10.2217/imt.14.75
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+T-cell cross-priming
- (2014) Cynthia M. Fehres et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models
- (2014) Amy L. Adlard et al. INTERNATIONAL JOURNAL OF CANCER
- Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant
- (2014) S. Adams et al. JOURNAL OF IMMUNOLOGY
- Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
- (2014) M. V. Dhodapkar et al. Science Translational Medicine
- Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation
- (2014) Austin Pantel et al. PLOS BIOLOGY
- TLR7 Expression is Decreased During Tumour Progression in Transgenic Adenocarcinoma of Mouse Prostate Mice and Its Activation Inhibits Growth of Prostate Cancer Cells
- (2013) Ju-Hee Han et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
- (2013) I. Le Mercier et al. CANCER RESEARCH
- Topical and Intralesional Treatment of Nonmelanoma Skin Cancer: Efficacy and Cost Comparisons
- (2013) Katelyn Chitwood et al. DERMATOLOGIC SURGERY
- Toll-like receptors as therapeutic targets for cancer
- (2013) Johanna Holldack DRUG DISCOVERY TODAY
- GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees
- (2013) Robert E. Lanford et al. GASTROENTEROLOGY
- Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion
- (2013) J. Tel et al. JOURNAL OF IMMUNOLOGY
- B Cell-Intrinsic TLR7 Signaling Is Required for Optimal B Cell Responses during Chronic Viral Infection
- (2013) J. M. Clingan et al. JOURNAL OF IMMUNOLOGY
- Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial
- (2013) Aimée HMM Arits et al. LANCET ONCOLOGY
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets
- (2012) J. Tel et al. BLOOD
- Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
- (2012) S. J. Dovedi et al. BLOOD
- TLR8: the forgotten relative revindicated
- (2012) Jorge L Cervantes et al. Cellular & Molecular Immunology
- Dendritic Cell-Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells
- (2012) Y. Dang et al. CLINICAL CANCER RESEARCH
- Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
- (2012) S. Adams et al. CLINICAL CANCER RESEARCH
- Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
- (2012) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients
- (2012) Simone M. Goldinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Intratracheal and oral administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer
- (2012) Erina Koga-Yamakawa et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer
- (2012) Xinqiang Hong et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
- (2012) Barbara Drobits et al. JOURNAL OF CLINICAL INVESTIGATION
- Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans
- (2012) Atsuo Ochi et al. JOURNAL OF CLINICAL INVESTIGATION
- A Combination of Local Inflammation and Central Memory T Cells Potentiates Immunotherapy in the Skin
- (2012) S. Fiorenza et al. JOURNAL OF IMMUNOLOGY
- TRAIL+ Human Plasmacytoid Dendritic Cells Kill Tumor Cells In Vitro: Mechanisms of Imiquimod- and IFN- -Mediated Antitumor Reactivity
- (2012) M. L. Kalb et al. JOURNAL OF IMMUNOLOGY
- Type I IFN Receptor and the B Cell Antigen Receptor Regulate TLR7 Responses via Distinct Molecular Mechanisms
- (2012) J. S. Poovassery et al. JOURNAL OF IMMUNOLOGY
- Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine
- (2012) Anna Wolska et al. LEUKEMIA & LYMPHOMA
- Le récepteur Toll-like8
- (2012) Lena Alexopoulou et al. M S-MEDECINE SCIENCES
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- Sex Differences in the Response to Viral Infections: TLR8 and TLR9 Ligand Stimulation Induce Higher IL10 Production in Males
- (2012) Maria Gabriella Torcia et al. PLoS One
- Regulation of TLR7/9 signaling in plasmacytoid dendritic cells
- (2012) Musheng Bao et al. Protein & Cell
- The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor signaling
- (2011) C. Seillet et al. BLOOD
- Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance
- (2011) C. Bourquin et al. CANCER RESEARCH
- Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
- (2011) F. Aranda et al. CANCER RESEARCH
- Phase I Study Utilizing a Novel Antigen-Presenting Cell-Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
- (2011) M. A. Morse et al. CLINICAL CANCER RESEARCH
- Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity
- (2011) Takumi Kawasaki et al. IMMUNOLOGICAL REVIEWS
- Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase
- (2011) Sarah E. Ewald et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Topical Imiquimod has Therapeutic and Immunomodulatory Effects Against Intracranial Tumors
- (2011) Zhengming Xiong et al. JOURNAL OF IMMUNOTHERAPY
- Immunomodulation by Imiquimod in Patients with High-Risk Primary Melanoma
- (2011) Rupa Narayan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission
- (2011) Barbara Beck et al. Journal of Translational Medicine
- The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
- (2011) Abbi L Engel et al. Expert Review of Clinical Pharmacology
- Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists
- (2010) D. Rajagopal et al. BLOOD
- Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
- (2010) Melissa A. Geller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice
- (2010) Fang Ma et al. Cellular & Molecular Immunology
- Stimulation of the endosomal TLR pathway enhances autophagy-induced cell death in radiotherapy of breast cancer
- (2010) Su-Jin Kang et al. Genes & Genomics
- Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
- (2010) Julien Cherfils-Vicini et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment Failure of a TLR-7 Agonist Occurs Due to Self-Regulation of Acute Inflammation and Can Be Overcome by IL-10 Blockade
- (2010) H. Lu et al. JOURNAL OF IMMUNOLOGY
- The TLR7 Agonist R848 Alleviates Allergic Inflammation by Targeting Invariant NKT Cells To Produce IFN-
- (2010) F. Grela et al. JOURNAL OF IMMUNOLOGY
- Delivery of Immunostimulatory RNA Oligonucleotides by Gelatin Nanoparticles Triggers an Efficient Antitumoral Response
- (2010) Carole Bourquin et al. JOURNAL OF IMMUNOTHERAPY
- Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
- (2010) Sara M. Mangsbo et al. JOURNAL OF IMMUNOTHERAPY
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Antitumor Activity and Immune Response Induction of a Dual Agonist of Toll-Like Receptors 7 and 8
- (2010) D. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling
- (2010) Su-Chang Lin et al. NATURE
- The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells
- (2009) Evelien L. J. M. Smits et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like Receptors 3 and 7 Agonists Enhance Tumor Cell Lysis by Human T Cells
- (2009) H. Shojaei et al. CANCER RESEARCH
- Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8
- (2009) Markus Janke et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immunostimulatory RNA Oligonucleotides Induce an Effective Antitumoral NK Cell Response through the TLR7
- (2009) C. Bourquin et al. JOURNAL OF IMMUNOLOGY
- Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy
- (2009) S. A. Broomfield et al. JOURNAL OF IMMUNOLOGY
- Murine B Cell Response to TLR7 Ligands Depends on an IFN- Feedback Loop
- (2009) N. M. Green et al. JOURNAL OF IMMUNOLOGY
- Selection of Molecular Structure and Delivery of RNA Oligonucleotides to Activate TLR7 versus TLR8 and to Induce High Amounts of IL-12p70 in Primary Human Monocytes
- (2009) A. Ablasser et al. JOURNAL OF IMMUNOLOGY
- Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists
- (2009) Svetlana Hamm et al. Journal of Immunotoxicology
- Imiquimod Enhances IFN-γ Production and Effector Function of T Cells Infiltrating Human Squamous Cell Carcinomas of the Skin
- (2009) Susan J. Huang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition
- (2009) Jin Liu et al. MOLECULAR IMMUNOLOGY
- Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1
- (2009) Angela Meier et al. NATURE MEDICINE
- NK1.1+ cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model
- (2008) Calin D. Dumitru et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma
- (2008) R. Dummer et al. CLINICAL CANCER RESEARCH
- Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies
- (2008) Karine Crozat et al. IMMUNOLOGICAL REVIEWS
- Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells
- (2008) Rachael A. Clark et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR7 Agonist 852A Inhibition of Tumor Cell Proliferation Is Dependent on Plasmacytoid Dendritic Cells and Type I IFN
- (2008) Jon R. Inglefield et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Signalling pathways leading to IFN-α production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications
- (2008) C. Guiducci et al. JOURNAL OF INTERNAL MEDICINE
- UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes
- (2008) You-Me Kim et al. NATURE
- The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
- (2008) E. L. J. M. Smits et al. ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search